Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Synthesis and antimicrobial activities of N6-hydroxyagelasine analogs and revision of the structure of ageloximes.

Paulsen B, Fredriksen KA, Petersen D, Maes L, Matheeussen A, Naemi AO, Scheie AA, Simm R, Ma R, Wan B, Franzblau S, Gundersen LL.

Bioorg Med Chem. 2019 Feb 15;27(4):620-629. doi: 10.1016/j.bmc.2019.01.002. Epub 2019 Jan 4.

PMID:
30638761
2.

Biofilms and their properties.

Valen H, Scheie AA.

Eur J Oral Sci. 2018 Oct;126 Suppl 1:13-18. doi: 10.1111/eos.12425. Review.

PMID:
30178559
3.

Environmental fate and effects of novel quorum sensing inhibitors that can control biofilm formation.

Lillicrap A, Macken A, Wennberg AC, Grung M, Rundberget JT, Fredriksen L, Scheie AA, Benneche T, d'Auriac MA.

Chemosphere. 2016 Dec;164:52-58. doi: 10.1016/j.chemosphere.2016.08.083. Epub 2016 Aug 28.

PMID:
27574814
4.

Specific quorum sensing-disrupting activity (A QSI) of thiophenones and their therapeutic potential.

Yang Q, Scheie AA, Benneche T, Defoirdt T.

Sci Rep. 2015 Dec 9;5:18033. doi: 10.1038/srep18033.

5.

The effect of metronidazole on the presence of P. gingivalis and T. forsythia at 3 and 12 months after different periodontal treatment strategies evaluated in a randomized, clinical trial.

Preus HR, Gjermo P, Scheie AA, Baelum V.

Acta Odontol Scand. 2015 May;73(4):258-66. doi: 10.3109/00016357.2014.920106. Epub 2015 Jan 20.

PMID:
25602128
7.

Thiophenone and furanone in control of Escherichia coli O103:H2 virulence.

Witsø IL, Benneche T, Vestby LK, Nesse LL, Lönn-Stensrud J, Scheie AA.

Pathog Dis. 2014 Apr;70(3):297-306. doi: 10.1111/2049-632X.12128. Epub 2014 Feb 3.

PMID:
24391047
8.

Synthetic brominated furanone F202 prevents biofilm formation by potentially human pathogenic Escherichia coli O103:H2 and Salmonella ser. Agona on abiotic surfaces.

Vestby LK, Johannesen KC, Witsø IL, Habimana O, Scheie AA, Urdahl AM, Benneche T, Langsrud S, Nesse LL.

J Appl Microbiol. 2014 Feb;116(2):258-68. doi: 10.1111/jam.12355. Epub 2013 Oct 25.

9.

Effect of chemical and mechanical debridement techniques on bacterial re-growth on rough titanium surfaces: an in vitro study.

Gustumhaugen E, Lönn-Stensrud J, Scheie AA, Lyngstadaas SP, Ekfeldt A, Taxt-Lamolle S.

Clin Oral Implants Res. 2014 Jun;25(6):707-13. doi: 10.1111/clr.12130. Epub 2013 Mar 12.

PMID:
23489326
10.

A quorum sensing-disrupting brominated thiophenone with a promising therapeutic potential to treat luminescent vibriosis.

Defoirdt T, Benneche T, Brackman G, Coenye T, Sorgeloos P, Scheie AA.

PLoS One. 2012;7(7):e41788. doi: 10.1371/journal.pone.0041788. Epub 2012 Jul 25.

11.

[Bacterial interactions may be a key to future antibiotics].

Lönn-Stensrud J, Benneche T, Scheie AA.

Lakartidningen. 2012 Apr 25-May 8;109(17-18):879-81. Review. Swedish. No abstract available.

PMID:
22642055
12.

Thiophenones inhibit Staphylococcus epidermidis biofilm formation at nontoxic concentrations.

Lönn-Stensrud J, Naemi AO, Benneche T, Petersen FC, Scheie AA.

FEMS Immunol Med Microbiol. 2012 Jul;65(2):326-34. doi: 10.1111/j.1574-695X.2012.00964.x. Epub 2012 Apr 23.

13.

The association between selected risk indicators and severity of peri-implantitis using mixed model analyses.

Koldsland OC, Scheie AA, Aass AM.

J Clin Periodontol. 2011 Mar;38(3):285-92. doi: 10.1111/j.1600-051X.2010.01659.x. Epub 2010 Dec 15.

PMID:
21158898
14.

Natural transformation of oral streptococci.

Petersen FC, Scheie AA.

Methods Mol Biol. 2010;666:167-80. doi: 10.1007/978-1-60761-820-1_12.

PMID:
20717785
15.

Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health?

Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP.

Microb Drug Resist. 2010 Jun;16(2):91-104. doi: 10.1089/mdr.2009.0120. Review.

PMID:
20370507
16.

Prevalence of peri-implantitis related to severity of the disease with different degrees of bone loss.

Koldsland OC, Scheie AA, Aass AM.

J Periodontol. 2010 Feb;81(2):231-8. doi: 10.1902/jop.2009.090269.

PMID:
20151801
17.

AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.

Ahmed NA, Petersen FC, Scheie AA.

Antimicrob Agents Chemother. 2009 Oct;53(10):4258-63. doi: 10.1128/AAC.00546-09. Epub 2009 Jul 13.

18.

Prevalence of implant loss and the influence of associated factors.

Koldsland OC, Scheie AA, Aass AM.

J Periodontol. 2009 Jul;80(7):1069-75. doi: 10.1902/jop.2009.080594.

PMID:
19563286
19.

Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections?

Lönn-Stensrud J, Landin MA, Benneche T, Petersen FC, Scheie AA.

J Antimicrob Chemother. 2009 Feb;63(2):309-16. doi: 10.1093/jac/dkn501. Epub 2008 Dec 20.

PMID:
19098295
20.

Biofilm formation and autoinducer-2 signaling in Streptococcus intermedius: role of thermal and pH factors.

Ahmed NA, Petersen FC, Scheie AA.

Oral Microbiol Immunol. 2008 Dec;23(6):492-7. doi: 10.1111/j.1399-302X.2008.00460.x.

PMID:
18954356
21.

Role of hyaluronidase in Streptococcus intermedius biofilm.

Pecharki D, Petersen FC, Scheie AA.

Microbiology. 2008 Mar;154(Pt 3):932-8. doi: 10.1099/mic.0.2007/012393-0.

PMID:
18310039
22.

LuxS and expression of virulence factors in Streptococcus intermedius.

Pecharki D, Petersen FC, Scheie AA.

Oral Microbiol Immunol. 2008 Feb;23(1):79-83. doi: 10.1111/j.1399-302X.2007.00395.x.

PMID:
18173802
23.

Synthetic bromated furanone inhibits autoinducer-2-mediated communication and biofilm formation in oral streptococci.

Lönn-Stensrud J, Petersen FC, Benneche T, Scheie AA.

Oral Microbiol Immunol. 2007 Oct;22(5):340-6.

PMID:
17803632
24.

AI-2 quorum sensing affects antibiotic susceptibility in Streptococcus anginosus.

Ahmed NA, Petersen FC, Scheie AA.

J Antimicrob Chemother. 2007 Jul;60(1):49-53. Epub 2007 May 9.

PMID:
17491000
25.

Intermolecular forces and enthalpies in the adhesion of Streptococcus mutans and an antigen I/II-deficient mutant to laminin films.

Busscher HJ, van de Belt-Gritter B, Dijkstra RJ, Norde W, Petersen FC, Scheie AA, van der Mei HC.

J Bacteriol. 2007 Apr;189(8):2988-95. Epub 2007 Feb 2.

26.
27.

Triclosan and antimicrobial resistance in bacteria: an overview.

Yazdankhah SP, Scheie AA, Høiby EA, Lunestad BT, Heir E, Fotland TØ, Naterstad K, Kruse H.

Microb Drug Resist. 2006 Summer;12(2):83-90. Review.

PMID:
16922622
28.

LuxS-mediated signalling in Streptococcus anginosus and its role in biofilm formation.

Petersen FC, Ahmed NA, Naemi A, Scheie AA.

Antonie Van Leeuwenhoek. 2006 Aug;90(2):109-21. Epub 2006 Aug 2.

PMID:
16897563
29.

Combined effects of NaF and SLS on acid- and polysaccharide-formation of biofilm and planktonic cells.

Petersen FC, Assev S, Scheie AA.

Arch Oral Biol. 2006 Aug;51(8):665-71. Epub 2006 Mar 15.

PMID:
16540078
30.

Inter-individual variation in the plaque formation rate of young individuals.

Aleksejūniene J, Scheie AA, Holst D.

Int J Dent Hyg. 2006 Feb;4(1):35-40.

PMID:
16451438
31.

Involvement of antigen I/II surface proteins in Streptococcus mutans and Streptococcus intermedius biofilm formation.

Pecharki D, Petersen FC, Assev S, Scheie AA.

Oral Microbiol Immunol. 2005 Dec;20(6):366-71.

PMID:
16238597
32.

DNA binding-uptake system: a link between cell-to-cell communication and biofilm formation.

Petersen FC, Tao L, Scheie AA.

J Bacteriol. 2005 Jul;187(13):4392-400.

33.
34.

THE BIOFILM CONCEPT: CONSEQUENCES FOR FUTURE PROPHYLAXIS OF ORAL DISEASES?

Scheie AA, Petersen FC.

Crit Rev Oral Biol Med. 2004 Jan 1;15(1):4-12.

PMID:
14761896
35.

Cariogenic traits in xylitol-resistant and xylitol-sensitive mutans streptococci.

Assev S, Stig S, Scheie AA.

Oral Microbiol Immunol. 2002 Apr;17(2):95-9.

PMID:
11929556
36.

Functional variation of the antigen I/II surface protein in Streptococcus mutans and Streptococcus intermedius.

Petersen FC, Assev S, van der Mei HC, Busscher HJ, Scheie AA.

Infect Immun. 2002 Jan;70(1):249-56.

37.

Expression and functional properties of the Streptococcus intermedius surface protein antigen I/II.

Petersen FC, Pasco S, Ogier J, Klein JP, Assev S, Scheie AA.

Infect Immun. 2001 Jul;69(7):4647-53.

38.

Genetic transformation in Streptococcus mutans requires a peptide secretion-like apparatus.

Petersen FC, Scheie AA.

Oral Microbiol Immunol. 2000 Oct;15(5):329-34.

PMID:
11154426
39.

Xylitol in caries prevention: what is the evidence for clinical efficacy?

Scheie AA, Fejerskov OB.

Oral Dis. 1998 Dec;4(4):268-78. Review.

PMID:
10200706
40.

Effects of mouth rinses with xylitol and fluoride on dental plaque and saliva.

Giertsen E, Emberland H, Scheie AA.

Caries Res. 1999;33(1):23-31.

PMID:
9831777
41.

The effects of xylitol-containing chewing gums on dental plaque and acidogenic potential.

Scheie AA, Fejerskov O, Danielsen B.

J Dent Res. 1998 Jul;77(7):1547-52.

PMID:
9663440
42.

Detection of microbial-derived fatty acids in carious dentin by gas chromatography and gas chromatography-mass spectrometry.

Brondz I, Nordbø H, Scheie AA.

J Chromatogr B Biomed Sci Appl. 1997 Oct 24;700(1-2):255-60.

PMID:
9390737
43.
46.

Mechanisms of dental plaque formation.

Scheie AA.

Adv Dent Res. 1994 Jul;8(2):246-53. Review.

PMID:
7865083
47.
49.

Effects of food preservatives on growth and metabolism of plaque bacteria in vitro and in vivo.

Leikanger S, Bjertness E, Scheie AA.

Scand J Dent Res. 1992 Dec;100(6):371-6.

PMID:
1465573
50.

Supplemental Content

Loading ...
Support Center